GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Molnupiravir Capsules 400mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Composition:
Each Hard gelatin capsule contains:
Molnupiravir …………………...200mg
Excipients……………………………...Q.S.
Colour used in capsule shell: Titanium dioxide Ph. Eur.
B. Molnupiravir Capsules 400mg
Composition:
Each Hard gelatin capsule contains:
Molnupiravir …………………...400mg
Excipients……………………………...Q.S.
Colour used in capsule shell: Sunset yellow FCF
THERAPEUTIC INDICATIONS:
This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed.
Molnupiravir drug has broad anti-influenza activity, which includes highly potent inhibition of SARS-CoV-2 replication.
CAUTION & WARNING:
FOR HOSPITAL ONLY
WARNING: To be sold by retail on the prescription of Registered Medical Practitioner only.
Do not skip/discontinue the dose for effective treatment.
Keep out of reach of children.
STORAGE & DOSAGE:
Do not refrigerate.
Dosage: As directed by the Physician.
Special Warning: Maintain hygiene, and do not come in contact with infected persons.
Note: Approved for Restricted use in Emergency.
Molnupiravir Capsules 200mg Technical Specification:
Product Name: | Molnupiravir Capsules 200mg |
Brand Name: | Molnutaj |
Strength: | 200mg, 400mg |
Dosage Form: | Hard gelatine Capsule |
Route of Administration: | Via oral Route |
Packing: | 10s Blisters 40 Tab Bottle |
Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
Therapeutic use: | Antiviral, COVID-19 |
Indication: | Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed. |
Storage: | Store protected from moisture at a temperature not exceeding 30°C. Do not refrigerate. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Molnupiravir Capsules 200mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Molnupiravir Capsules 200mg
Composition:
Each Hard gelatin capsule contains:
Molnupiravir ……………………200mg
Excipients………………………………Q.S.
Colour used in capsule shell: Titanium dioxide Ph. Eur.
THERAPEUTIC INDICATIONS:
Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.
This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed.
Molnupiravir drug has broad anti-influenza activity, which includes highly potent inhibition of SARS-CoV-2 replication.
CAUTION & WARNING:
CAUTION: Do not swallow whole or chew.
FOR HOSPITAL ONLY
WARNING: To be sold by retail on the prescription of Registered Medical Practitioner only.
Do not skip/discontinue the dose for effective treatment.
Keep out of reach of children.
STORAGE & DOSAGE:
Storage: Store protected from moisture at a temperature not exceeding 30°C.
Do not refrigerate.
Dosage: As directed by the Physician.
Special Warning: Maintain hygiene, and do not come in contact with infected persons.
Note: Approved for Restricted use in Emergency.